Both loss and gain of function experiments demonstrate that GATA-2 level regulates adult HSC quiescence and modulates HSC apoptosis[15], which could affect the responses to chemotherapy and contribute to poor prognosis in AML. Here, GATA2 is linked to acute myeloid leukemia.